Subclinical left ventricular dysfunction in Behcet's disease assessed by two-dimensional speckle tracking echocardiography

European Journal of Echocardiography

Volumn 12, Issue 7, 2011, Pages 536-541

  Yagmur, Julide ^a   Sener, Serpil ^a   Acikgoz, Nusret ^a   Cansel, Mehmet ^a   Ermis, Necip ^a   Karincaoglu, Yelda ^a   Tasolar, Hakan ^a   Karakus, Yasin ^a   Pekdemir, Hasan ^a   Ozdemir, Ramazan ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; N terminal pro B type natriuretic peptide; Speckle tracking echocardiography

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BEHCET DISEASE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; IMAGING SYSTEM; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; SPECKLE TRACKING ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

BEHCET SYNDROME; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; HEART VENTRICLES; HUMANS; LINEAR MODELS; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80052019995     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jer088     Document Type: Article

References (34)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-91. (Pubitemid 29489745)
2. Yazici H. Behcet's syndrome: an update. Curr Rheumatol Rep 2003;5:195-9.
3. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behcet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16:790-5. (Pubitemid 15040814)
4. Bletry O, Motattane A, Wechsler B, Beaufils P, Valere P, Petit J et al. Cardiac manifestation of Behcet's disease. Twelve cases. Presse Med 1988;17:2388-91. (Pubitemid 19019699)
5. Huong DL, Wechsler B, Papo T, de Zuttere D, Bletry O, Hernigou A et al. Endomyocardial fibrosis in Behçet's disease. Ann Rheum Dis 1997;56:205-8.
6. Ehrlich GE. Vasculitis in Behcet's disease. Int Rev Immunol 1997;14:81-8. (Pubitemid 27188574)
7. Sakane T. New perspective on Behcet's disease. Int Rev Immunol 1997;14:89-96. (Pubitemid 27185416)
8. Goldeli O, Ural D, Komsuoglu B, Agacdiken A, Dursun E, Cetinaslan B. Abnormal QT dispersion in Behcet's disease. Int J Cardiol 1997;61:55-9. (Pubitemid 27366266)
9. Baris N, Okan T, Gurler O, Akdeniz B, Turker S, Ilknur T et al. Evaluation of left ventricular diastolic dysfunction with conventional and current Doppler techniques in Behcet's disease. Clin Rheumatol 2006;25:873-6. (Pubitemid 44473156)
10. Topal E, Ozdemir R, Aksoy Y, Acikgoz N, Ermis N, Sincer I et al. Tissue Doppler velocities of the right and left ventricles and their association with C-reactive protein and homocysteine levels in Behcet's disease. Am J Cardiol 2005;96:1739-42. (Pubitemid 41790402)
11. Yavuz B, Sahiner L, Akdogan A, Abali G, Aytemir K, Tokgozoglu L et al. Left and right ventricular function is impaired in Behcet's disease. Echocardiography 2006;23:723-8. (Pubitemid 44450525)
12. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol 2006;47:1313-27.
13. Bansal M, Cho GY, Chan J, Leano R, Haluska BA, Marwick TH. Feasibility and accuracy of different techniques of two-dimensional speckle based strain and validation with harmonic phase magnetic resonance imaging. J Am Soc Echocardiogr 2008;21:1318-25.
14. Teske AJ, De Boeck BW, Melman PG, Sieswerda GT, Doevendans PA, Cramer MJ. Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking. Cardiovasc Ultrasound 2007;5:27.
15. Matias C, Isla LP, Vasconcelos M et al. Speckle-tracking-derived strain and strainrate analysis: a technique for the evaluation of early alterations in right ventricle systolic function in patients with systemic sclerosis and normal pulmonary artery pressure. J Cardiovasc Med 2009;10:129-34.
16. Cheung YF, Liang XC, Chan GC, Wong SJ, Ha SY. Myocardial deformation in patients with Beta-thalassemia major: a speckle tracking echocardiographic study. Echocardiography 2010;27:253-9.
17. International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80.
18. Gullu HI, Benekli M, Müderrisoglu H, Oto A, Kansu E, Kabakçi G et al. Silent myocardial ischemia in Behcet's disease. J Rheumatol 1996;23:323-7.
19. Atzeni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani C. Behcet's disease and cardiovascular involvement. Lupus 2005;14:723-6.
20. Kosar F, Sahin I, Gullu H, Cehreli S. Acute myocardial infarction with normal coronary arteries in a young man with the Behcet's disease. Int J Cardiol 2005;99:355-7. (Pubitemid 40320819)
21. Calgüneri M, Erbas B, Kes S, Karaaslan S. Alterations in left ventricular function in Behçet's disease using radionuclide ventriculography. Cardiology 1993;82:309-16. (Pubitemid 23245972)
22. Kaya E, Saglam H, Ciftci I, Kulac M, Karaca S, Melek M. Evaluation of myocardial perfusion and function by gated SPECT in patients with Behçet's disease. Ann Nucl Med 2008;22:287-95. (Pubitemid 351809791)
23. Turkolmez S, Gokcora N, Alkan M, Gürer MA. Evaluation of myocardial perfusion in patients with Behçet's disease. Ann Nucl Med 2005;19:201-6. (Pubitemid 40874512)
24. Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Shanks M et al. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2009;104:1398-401.
25. Greenbaum RA, Ho SY, Gibson DG, Becker AE, Anderson RH. Left ventricular fibre architecture in man. Br Heart J 1981;45:248-63. (Pubitemid 11137851)
26. Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr 2008;21:1138-44.
27. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res 2006;69:318-28. (Pubitemid 43098788)
28. Felker GM, Petersen JW, Mark DB. Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 2006;175:611-7. (Pubitemid 44439724)
29. Takase H, Toriyama T, Sugiura T, Takahashi A, Sugiyama M, Ohashi M et al. Brain natriuretic peptide detects cardiac abnormalities in mass screening. Eur J Clin Invest 2007;37:257-62. (Pubitemid 46439413)
30. Targońska-Stȩpniak B, Majdan M. Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis. Clin Rheumatol 2011;30:61-9.
31. Solus J, Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintoni A et al. Aminoterminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum 2008;58:2662-9.
32. Karadag O, Calguneri M, Yavuz B, Atalar E, Akdogan A, Kalyoncu U et al. B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance? Clin Rheumatol 2007;26:1701-4.
33. Yagci R, Totan Y, Ozlük E, Ozyurt H, Akbay G, Eksioglu M. Serum levels of natriuretic peptides in patients with Behcet's disease. Clin Rheumatol 2008;27:1153-8.
34. Yoneyama A, Koyama J, Tomita T, Kumazaki S, Tsutsui H, Watanabe N et al. Relationship of plasma brain-type natriuretic peptide levels to left ventricular longitudinal function in patients with congestive heart failure by strain Doppler imaging. Int J Cardiol 2008;130:56-63.